Similarly, HOXD13 was overexpressed in GBM compared to WHO Grade 3 glioma (confirmed by TCGA and CGGA), LGG (confirmed by TCGA, CGGA, Rembrandt, and qPCR), and normal brain tissue (confirmed by Rembrandt and qPCR). The gene discussed is HOXD13; the disease is central nervous system cancer.